BLFS - Company ID 0000834365
The table below shows BIOLIFE SOLUTIONS INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $27.50M | $28.07M | $25.42M | $22.05M | $21.39M | $19.71M |
| Cost of revenue | $10.00M | - | - | $7.25M | - | - |
| Gross profit | $17.50M | - | - | $14.80M | - | - |
| R&D | $2.65M | $2.71M | $2.72M | $1.44M | $1.89M | $2.03M |
BIOLIFE SOLUTIONS INC reported annual revenue of $96.21M for fiscal year 2025. That is up 28.9% from $74.65M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $6.19M (FY 2014) to $96.21M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $12.21M |
| $12.07M |
| $11.40M |
| $11.35M |
| $9.33M |
| $9.32M |
| Operating income | $27.00K | -$89.00K | -$16.64M | -$499.00K | -$418.00K | -$1.31M |
| Income tax | $62.00K | $82.00K | $126.00K | $14.00K | -$80.00K | $1.00K |
| Net income | $1.19M | $621.00K | -$15.84M | -$448.00K | -$1.70M | -$20.72M |
| EPS (diluted) | $0.02 | $0.01 | -$0.33 | $0.00 | -$0.04 | -$0.45 |